Streetbeat News

Price Targets

RYTM

Wells Fargo analyst Derek Archila has maintained an Overweight rating on Rhythm Pharmaceuticals (NASDAQ:RYTM) and increased the price target from $48 to $53.

Portfolio Pulse from Benzinga Newsdesk

December 19, 2023 | 1:28 pm

KMPR

Piper Sandler analyst Paul Newsome has maintained an Overweight rating on Kemper Corporation (NYSE:KMPR) and increased the price target from $47 to $56. This adjustment reflects a positive outlook on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

December 19, 2023 | 1:26 pm

BPMC

Wells Fargo analyst Derek Archila has maintained an Overweight rating on Blueprint Medicines (NASDAQ:BPMC) and increased the price target from $86 to $115.

Portfolio Pulse from Benzinga Newsdesk

December 19, 2023 | 1:26 pm

ASND

Wells Fargo analyst Derek Archila has reaffirmed an Overweight rating on Ascendis Pharma (NASDAQ:ASND) and increased the price target from $137 to $149. This adjustment reflects a positive outlook on the company's stock, suggesting potential upside from its current trading level.

Portfolio Pulse from Benzinga Newsdesk

December 19, 2023 | 1:23 pm

DXCM

Piper Sandler analyst Matt O'Brien has maintained an Overweight rating on DexCom (NASDAQ:DXCM) and increased the price target from $135 to $150.

Portfolio Pulse from Benzinga Newsdesk

December 19, 2023 | 1:22 pm

KRON

Piper Sandler analyst Edward Tenthoff has maintained an Overweight rating on Kronos Bio (NASDAQ:KRON) but reduced the price target from $7 to $6.

Portfolio Pulse from Benzinga Newsdesk

December 19, 2023 | 1:20 pm

NOK

Goldman Sachs analyst Alexander Duval has maintained a Neutral rating on Nokia (NYSE:NOK) but has reduced the price target from $5.1 to $3.4.

Portfolio Pulse from Benzinga Newsdesk

December 19, 2023 | 1:19 pm

USB

Goldman Sachs analyst Richard Ramsden has maintained a Neutral rating on U.S. Bancorp (NYSE:USB) and increased the price target from $37 to $42.

Portfolio Pulse from Benzinga Newsdesk

December 19, 2023 | 1:17 pm

PNC

Goldman Sachs analyst Richard Ramsden has maintained a Neutral rating on PNC Financial Services Group (PNC) and increased the price target from $128 to $147.

Portfolio Pulse from Benzinga Newsdesk

December 19, 2023 | 1:14 pm

GS

PJT

Goldman Sachs analyst Richard Ramsden has reaffirmed a Buy rating on PJT Partners and increased the price target from $96 to $108.

Portfolio Pulse from Benzinga Newsdesk

December 19, 2023 | 1:13 pm